Park M S, Heimbürger O, Bergström J, Waniewski J, Werynski A, Lindholm B
Department of Renal Medicine, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
Perit Dial Int. 1993;13(4):280-8.
To evaluate the potential clinical role of amino acids as an osmotic agent.
The peritoneal transport of fluid, amino acids, and other solutes was investigated during a 6-hour single-cycle peritoneal dialysis with PDA 1% versus 1.36% glucose (n = 6) or PDA 2.7% versus 3.86% glucose solution (n = 9).
Fifteen stable nondiabetic continuous ambulatory peritoneal dialysis (CAPD) patients.
The fractional absorption of the osmotic agents at 6 hours was higher with PDA 2.7% versus glucose 3.86% (p < 0.005). The diffusive mass transport coefficient, KBD, calculated for a period of dialysate isovolemia was higher with PDA 2.7% versus PDA 1% for essential, nonessential (p < 0.005), and total (p < 0.05) amino acids. The intraperitoneal volume-over-time curves and KBD values for urea, creatinine, glucose, albumin, beta 2-microglobulin, and total protein did not differ between the amino acid solutions and the corresponding glucose solutions. KBD for urea was significantly higher during the dwell with PDA 2.7% versus PDA 1% (p < 0.05). Plasma amino acid concentrations increased substantially during the first 1-2 hours and then decreased gradually. Valine and methionine rose to 792% and 1119% of baseline values, respectively.
We conclude that the peritoneal transport of fluid and investigated solutes, except amino acids, was not different with the amino acid solutions compared with the corresponding equimolar glucose solutions. However, ultrafiltration tended to be lower with amino acid solutions. Furthermore, the fractional absorption of amino acids and KBD values for amino acids was higher with PDA 2.7% versus PDA 1%, suggesting an effect of the hypertonic amino acid solution on the peritoneal membrane transport properties. Also, the hypertonic PDA 2.7% solution yielded nonphysiologically high plasma levels of several amino acids. We therefore consider this solution not to be safe enough for long-term clinical use.
评估氨基酸作为渗透剂的潜在临床作用。
在6小时单周期腹膜透析过程中,研究了1% PDA与1.36%葡萄糖(n = 6)或2.7% PDA与3.86%葡萄糖溶液(n = 9)时液体、氨基酸及其他溶质的腹膜转运情况。
15例稳定的非糖尿病持续性非卧床腹膜透析(CAPD)患者。
2.7% PDA组6小时时渗透剂的分数吸收高于3.86%葡萄糖组(p < 0.005)。在透析液等容期计算得出的必需氨基酸、非必需氨基酸(p < 0.005)及总氨基酸(p < 0.05)的扩散质量转运系数KBD,2.7% PDA组高于1% PDA组。氨基酸溶液和相应葡萄糖溶液之间,尿素肌酐、葡萄糖、白蛋白、β2 -微球蛋白及总蛋白的腹膜内体积 - 时间曲线和KBD值无差异。2.7% PDA留存期间尿素的KBD显著高于1% PDA组(p < 0.05)。血浆氨基酸浓度在最初1 - 2小时大幅升高,随后逐渐下降。缬氨酸和蛋氨酸分别升至基线值的792%和1119%。
我们得出结论,与相应的等摩尔葡萄糖溶液相比,氨基酸溶液对液体及所研究溶质(氨基酸除外)的腹膜转运无差异。然而,氨基酸溶液的超滤作用往往较低。此外,2.7% PDA组氨基酸的分数吸收和KBD值高于1% PDA组,提示高渗氨基酸溶液对腹膜转运特性有影响。而且,高渗2.7% PDA溶液使几种氨基酸的血浆水平升高至非生理性的高水平。因此,我们认为该溶液长期临床使用安全性不足。